
Chemomab Therapeutics Ltd.
CMMBHealthcare|Biotechnology|IL
$1.32
+0.07 (+5.60%)
DCF Value
$1.56
Tangible Book / Share
$1.09
Cash / Share
$0.84
Ownership Breakdown
88.6%
Float
6.8M
Shares Outstanding
6.0M
Float Shares
Major Holders (17)
Combined: 93.0%
Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.
| Holder | Type | % of Class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| HBM Healthcare Investments (Cayman) Ltd. | Corporation | 12.50% | 80,971,680 | Sep 9, 2026 | 13D/G |
| Morgan Stanley | HC, CO | 8.40% | 32,282,680 | Aug 7, 2025 | 13D/G |
| Otto Erik | Individual | 6.30% | 385,000 | Feb 10, 2026 | 13D/G |
| Erik Otto | Individual | 6.10% | 1,155,000 | Nov 21, 2024 | 13D/G |
| Touchstone Global Investments Pty Ltd | Corporation | 5.20% | 377,814 | Aug 13, 2026 | 13D/G |
| Orbimed Israel Biofund GP Limited Partnership | Partnership | 4.80% | 969,807 | Jun 23, 2025 | 13D/G |
| Gordon Carl L | Individual | 4.80% | 969,807 | Jun 23, 2025 | 13D/G |
| Chimovits Erez | Individual | 4.80% | 969,807 | Jun 23, 2025 | 13D/G |
| Orbimed Israel GP LTD. | Corporation | 4.80% | 969,807 | Jun 23, 2025 | 13D/G |
| Adi Mor | Individual | 4.80% | 898,221 | Nov 29, 2024 | 13D/G |
| Kobi George | Individual | 4.80% | 898,221 | Nov 29, 2024 | 13D/G |
| Sphera Funds Management Ltd. | Corporation | 4.78% | 900,428 | Apr 10, 2025 | 13D/G |
| Sphera Global Healthcare Management LP. | Partnership | 4.78% | 900,428 | Apr 10, 2025 | 13D/G |
| Sphera Global Healthcare GP Ltd. | Corporation | 4.78% | 900,428 | Apr 10, 2025 | 13D/G |
| Peter Thiel | Individual | 4.60% | 22,631,200 | Feb 17, 2026 | 13D/G |
| Rivendell Investments 2017-9 LLC | Other | 4.60% | 22,631,200 | Feb 17, 2026 | 13D/G |
| Morgan Stanley & Co. LLC | BD, CO | 2.20% | 9,275,360 | Aug 7, 2025 | 13D/G |
Insider Trades (100)
Last 4 quarters: 8,993 acquired · 62,570 disposed
| Insider | Position | Date | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Cohen Neil Harris | director | Aug 27, 2026 | SELL | 1,304 | $2.85 | $3.7K | Form 4 |
| Cohen Neil Harris | director | Aug 28, 2026 | SELL | 1,000 | $2.80 | $2.8K | Form 4 |
| Cohen Neil Harris | director | Mar 16, 2026 | AWARD | 5,172 | $2.14 | $11.1K | Form 4 |
| Cohen Neil Harris | director | Mar 16, 2025 | AWARD | 3,821 | $6.16 | $23.5K | Form 4 |
| Cohen Neil Harris | director | Mar 18, 2024 | AWARD | 2,520 | $2.96 | $7.5K | Form 4 |
| Cohen Neil Harris | director | Mar 21, 2023 | AWARD | 1,714 | $6.48 | $11.1K | Form 4 |
| Cohen Neil Harris | director | Mar 7, 2022 | AWARD | 1,705 | $14.12 | $24.1K | Form 4 |
| Cohen Neil Harris | director | Apr 19, 2021 | AWARD | 2,971 | $109.04 | $324.0K | Form 4 |
| Cohen Neil Harris | director | Jul 16, 2020 | AWARD | 172 | $52.80 | $9.1K | Form 4 |
| Melincoff Gwen A | director | Jun 1, 2026 | OTHER | 8,621 | $1.86 | $16.0K | Form 4 |
| Mor George Adi | director, officer: Chief Executive Officer | May 29, 2026 | BUY | 4,926 | $2.08 | $10.2K | Form 4 |
| Mor George Adi | director, officer: Chief Executive Officer | May 29, 2026 | BUY | 4,878 | $2.05 | $10.0K | Form 4 |
| Mor George Adi | director, officer: Chief Executive Officer | May 29, 2026 | DISPOSED | 31,712 | — | — | Form 4 |
| Mor George Adi | director, officer: Chief Executive Officer | May 29, 2026 | DISPOSED | 18,750 | — | — | Form 4 |
| Mor George Adi | director, officer: Chief Executive Officer | Mar 18, 2026 | OTHER | 0 | — | — | Form 4 |
| Mor George Adi | director, officer: Chief Executive Officer | Mar 18, 2026 | OTHER | 0 | — | — | Form 4 |
| Mor George Adi | director, officer: Chief Executive Officer | Mar 18, 2026 | OTHER | 0 | — | — | Form 4 |
| Mor George Adi | director, officer: Chief Executive Officer | Mar 18, 2026 | OTHER | 0 | — | — | Form 4 |
| Mor George Adi | director, officer: Chief Executive Officer | Mar 18, 2026 | OTHER | 32,925 | $5.94 | $195.6K | Form 4 |
| Mor George Adi | director, officer: Chief Executive Officer | Mar 18, 2026 | OTHER | 109,718 | $5.16 | $566.1K | Form 4 |
| Mor George Adi | director, officer: Chief Executive Officer | Mar 18, 2026 | OTHER | 8,431 | $3.20 | $27.0K | Form 4 |
| Darvish Nissim | director | Mar 18, 2026 | OTHER | 0 | — | — | Form 4 |
| Darvish Nissim | director | Mar 18, 2026 | OTHER | 2,531 | $3.20 | $8.1K | Form 4 |
| Darvish Nissim | director | Mar 18, 2026 | OTHER | 2,971 | $109.04 | $324.0K | Form 4 |
| Darvish Nissim | director | Mar 18, 2026 | OTHER | 1,705 | $14.12 | $24.1K | Form 4 |
| Darvish Nissim | director | Mar 18, 2026 | OTHER | 1,714 | $6.48 | $11.1K | Form 4 |
| Darvish Nissim | director | Mar 18, 2026 | OTHER | 5,143 | $6.80 | $35.0K | Form 4 |
| Darvish Nissim | director | Mar 18, 2026 | OTHER | 4,221 | $3.44 | $14.5K | Form 4 |
| Darvish Nissim | director | Jun 1, 2026 | OTHER | 6,599 | $5.24 | $34.6K | Form 4 |
| Cohen Neil Harris | director | Mar 18, 2026 | OTHER | 0 | — | — | Form 4 |
| Cohen Neil Harris | director | Mar 18, 2026 | OTHER | 172 | $52.80 | $9.1K | Form 4 |
| Cohen Neil Harris | director | Mar 18, 2026 | OTHER | 2,971 | $109.04 | $324.0K | Form 4 |
| Cohen Neil Harris | director | Mar 18, 2026 | OTHER | 1,705 | $14.12 | $24.1K | Form 4 |
| Cohen Neil Harris | director | Mar 18, 2026 | OTHER | 1,714 | $6.48 | $11.1K | Form 4 |
| Cohen Neil Harris | director | Mar 18, 2026 | OTHER | 2,520 | $2.96 | $7.5K | Form 4 |
| Cohen Neil Harris | director | Mar 18, 2026 | OTHER | 3,821 | $6.16 | $23.5K | Form 4 |
| Cohen Neil Harris | director | Mar 16, 2027 | OTHER | 5,172 | $2.14 | $11.1K | Form 4 |
| Moses Alan Charles | director | Mar 18, 2026 | OTHER | 1,705 | $14.12 | $24.1K | Form 4 |
| Moses Alan Charles | director | Mar 18, 2026 | OTHER | 2,971 | $109.04 | $324.0K | Form 4 |
| Moses Alan Charles | director | Mar 18, 2026 | OTHER | 1,714 | $6.48 | $11.1K | Form 4 |
| Moses Alan Charles | director | Mar 18, 2026 | OTHER | 2,520 | $2.96 | $7.5K | Form 4 |
| Moses Alan Charles | director | Mar 18, 2026 | OTHER | 3,821 | $6.16 | $23.5K | Form 4 |
| Moses Alan Charles | director | Mar 16, 2027 | OTHER | 5,172 | $2.14 | $11.1K | Form 4 |
| Fatal Sigal | Chief Financial Officer | Mar 18, 2026 | OTHER | 0 | — | — | Form 4 |
| Fatal Sigal | Chief Financial Officer | Mar 18, 2026 | OTHER | 0 | — | — | Form 4 |
| Fatal Sigal | Chief Financial Officer | Mar 18, 2026 | OTHER | 0 | — | — | Form 4 |
| Fatal Sigal | Chief Financial Officer | Mar 18, 2026 | OTHER | 7,350 | $8.44 | $62.0K | Form 4 |
| Fatal Sigal | Chief Financial Officer | Mar 18, 2026 | OTHER | 25,715 | $6.80 | $174.9K | Form 4 |
| Fatal Sigal | Chief Financial Officer | Mar 18, 2026 | OTHER | 8,900 | $39.31 | $349.9K | Form 4 |
| Lawler John | Chief Development Officer | Mar 18, 2026 | OTHER | 0 | — | — | Form 4 |
| Lawler John | Chief Development Officer | Mar 18, 2026 | OTHER | 0 | — | — | Form 4 |
| Lawler John | Chief Development Officer | Mar 18, 2026 | OTHER | 0 | — | — | Form 4 |
| Lawler John | Chief Development Officer | Mar 18, 2026 | OTHER | 10,864 | $5.68 | $61.7K | Form 4 |
| Lawler John | Chief Development Officer | Mar 18, 2026 | OTHER | 12,500 | $20.52 | $256.5K | Form 4 |
| Lawler John | Chief Development Officer | Mar 18, 2026 | OTHER | 7,500 | $2.20 | $16.5K | Form 4 |
| Quigley Jill M. | director | Jun 16, 2026 | OTHER | 3,959 | $5.24 | $20.7K | Form 4 |
| Quigley Jill M. | director | Mar 18, 2026 | OTHER | 3,410 | $13.00 | $44.3K | Form 4 |
| Quigley Jill M. | director | Mar 18, 2026 | OTHER | 1,714 | $6.80 | $11.7K | Form 4 |
| Quigley Jill M. | director | Mar 18, 2026 | OTHER | 2,533 | $4.00 | $10.1K | Form 4 |
| Nicaise Claude | director | Mar 18, 2026 | OTHER | 3,821 | $6.16 | $23.5K | Form 4 |
| Nicaise Claude | director | Mar 16, 2027 | OTHER | 5,172 | $2.14 | $11.1K | Form 4 |
| Nicaise Claude | director | Mar 18, 2026 | OTHER | 2,520 | $2.96 | $7.5K | Form 4 |
| Nicaise Claude | director | Mar 18, 2026 | OTHER | 2,971 | $109.04 | $324.0K | Form 4 |
| Nicaise Claude | director | Mar 18, 2026 | OTHER | 1,705 | $14.12 | $24.1K | Form 4 |
| Nicaise Claude | director | Mar 18, 2026 | OTHER | 1,714 | $6.48 | $11.1K | Form 4 |
| Darvish Nissim | director | Jun 14, 2023 | AWARD | 20,572 | $1.70 | $35.0K | Form 4 |
| Darvish Nissim | director | Apr 19, 2021 | AWARD | 11,884 | $27.26 | $324.0K | Form 4 |
| Darvish Nissim | director | Oct 28, 2016 | AWARD | 10,123 | $0.80 | $8.1K | Form 4 |
| Darvish Nissim | director | Mar 16, 2023 | AWARD | 6,857 | $1.62 | $11.1K | Form 4 |
| Darvish Nissim | director | Mar 7, 2022 | AWARD | 6,820 | $3.53 | $24.1K | Form 4 |
| Quigley Jill M. | director | Jun 16, 2023 | AWARD | 6,857 | $1.71 | $11.7K | Form 4 |
| Quigley Jill M. | director | Jun 16, 2022 | AWARD | 13,640 | $3.25 | $44.3K | Form 4 |
| Fatal Sigal | Chief Financial Officer | Jun 14, 2023 | AWARD | 102,860 | $1.70 | $174.9K | Form 4 |
| Fatal Sigal | Chief Financial Officer | Nov 8, 2022 | AWARD | 29,400 | $2.11 | $62.0K | Form 4 |
| Fatal Sigal | Chief Financial Officer | Nov 11, 2021 | AWARD | 35,600 | $9.83 | $349.9K | Form 4 |
| Fatal Sigal | Chief Financial Officer | Jun 1, 2023 | DISPOSED | 0 | — | — | Form 4 |
| Fatal Sigal | Chief Financial Officer | Jun 1, 2023 | DISPOSED | 35,600 | $9.83 | $349.9K | Form 4 |
| Fatal Sigal | Chief Financial Officer | Jun 1, 2023 | DISPOSED | 29,400 | $2.11 | $62.0K | Form 4 |
| Moses Alan Charles | director | Mar 16, 2023 | AWARD | 6,857 | $1.62 | $11.1K | Form 4 |
| Moses Alan Charles | director | Mar 7, 2022 | AWARD | 6,820 | $3.53 | $24.1K | Form 4 |
| Nicaise Claude | director | Mar 16, 2023 | AWARD | 11,884 | $27.26 | $324.0K | Form 4 |
| Nicaise Claude | director | Mar 16, 2023 | AWARD | 6,857 | $1.62 | $11.1K | Form 4 |
| Nicaise Claude | director | Mar 16, 2023 | AWARD | 6,820 | $3.53 | $24.1K | Form 4 |
| Cohen Neil Harris | director | Mar 16, 2023 | AWARD | 6,875 | $1.62 | $11.1K | Form 4 |
| OrbiMed Israel GP Ltd. | director | Jan 3, 2023 | SELL | 266,376 | $3.34 | $889.7K | Form 4 |
| OrbiMed Israel GP Ltd. | director | Jan 3, 2023 | SELL | 70,524 | $4.51 | $318.1K | Form 4 |
| Mor George Adi | Chief Scientific Officer | Jan 3, 2023 | SELL | 7,700 | $5.03 | $38.7K | Form 4 |
| Mor George Adi | Chief Scientific Officer | Jan 3, 2023 | SELL | 6,100 | $5.03 | $30.7K | Form 4 |
| Mor George Adi | Chief Scientific Officer | Mar 15, 2018 | AWARD | 131,698 | — | — | Form 4 |
| Mor George Adi | Chief Scientific Officer | Oct 28, 2016 | AWARD | 33,725 | — | — | Form 4 |
| Cohen Neil Harris | director | Nov 16, 2022 | SELL | 2,409 | $2.00 | $4.8K | Form 4 |
| Cohen Neil Harris | director | Mar 7, 2022 | AWARD | 6,820 | $3.53 | $24.1K | Form 4 |
| Cohen Neil Harris | director | Mar 16, 2021 | AWARD | 688 | $13.17 | $9.1K | Form 4 |
| Mor George Adi | Chief Scientific Officer | Nov 16, 2022 | SELL | 324,775 | $2.08 | $677.1K | Form 4 |
| Mor George Adi | Chief Scientific Officer | Nov 16, 2022 | SELL | 257,248 | $2.08 | $536.3K | Form 4 |
| Mor George Adi | Chief Scientific Officer | Mar 15, 2018 | AWARD | 131,698 | — | — | Form 4 |
| Mor George Adi | Chief Scientific Officer | Oct 28, 2016 | AWARD | 33,725 | — | — | Form 4 |
| Frankel Matthew Bejosa | Chief Medical Officer | Nov 14, 2022 | DISPOSED | 125,000 | $2.07 | $258.7K | Form 4 |
| Quigley Jill M. | director | Jun 16, 2022 | DISPOSED | 13,640 | $3.25 | $44.3K | Form 4 |
| Marvin Donald | Executive VP, CFO & COO | Mar 16, 2022 | AWARD | 196,875 | — | — | Form 4 |